Announcements
- KALA BIO to Present at Jefferies Global Healthcare Conference
- KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
- KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
- KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
- KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
- KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Participate in Upcoming Investor Conferences in August
More ▼
Key statistics
On Friday, KALA BIO Inc (27F0:FRA) closed at 5.54, 16.72% above the 52 week low of 4.74 set on Nov 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.50 |
---|---|
High | 5.54 |
Low | 5.50 |
Bid | 5.45 |
Offer | 5.66 |
Previous close | 5.57 |
Average volume | 212.00 |
---|---|
Shares outstanding | 2.82m |
Free float | 2.58m |
P/E (TTM) | -- |
Market cap | 16.79m USD |
EPS (TTM) | -15.15 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 14:58 BST.
More ▼